Sugai, Keiji
Miwa, Takashi
Kojima, Junya
Ueda, Yuri
Tsukahara, Kiyoaki
Nishi, Hirotaka
Suzuki, Ryo
Article History
Received: 31 January 2024
Accepted: 10 March 2024
First Online: 19 March 2024
Compliance with ethical standards
:
: K.T. received speakers bureaus from Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company. R.S. received honoraria, subsidies, and donations from Novo Nordisk Inc., Sanofi K.K., Sumitomo Pharma Co., Ltd., Astellas Pharma Inc., Kowa Co., Ltd., MSD K.K., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Co., Teijin Pharma, Ltd., Ono Pharmaceutical Co., Ltd., Daiichi Sankyo co., Ltd., Sanwa Kagaku Kenkyusho, Ltd., Takeda Pharmaceutical Co., Ltd., and Nippon Boehringer Ingelheim Co. The remaining authors declare that they have no conflicts of interest.
: Written informed consent for publication was obtained from the patient and legal guardian of the minor.